Redmile Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,535
| Closed | -$578K | – | 83 |
|
|
2020
Q1 | $578K | Sell |
2,535
-10,903
| -81% | -$2.49M | 0.02% | 65 |
|
|
2019
Q4 | $7.11M | Sell |
13,438
-6,538
| -33% | -$3.46M | 0.17% | 57 |
|
|
2019
Q3 | $8.61M | Sell |
19,976
-108
| -0.5% | -$46.6K | 0.29% | 55 |
|
|
2019
Q2 | $23.9M | Sell |
20,084
-98
| -0.5% | -$117K | 0.68% | 45 |
|
|
2019
Q1 | $25.1M | Buy |
20,182
+397
| +2% | +$495K | 0.74% | 41 |
|
|
2018
Q4 | $18.7M | Sell |
19,785
-696
| -3% | -$659K | 0.75% | 42 |
|
|
2018
Q3 | $29.5M | Buy |
20,481
+188
| +0.9% | +$271K | 0.91% | 41 |
|
|
2018
Q2 | $32.7M | Sell |
20,293
-2,530
| -11% | -$4.08M | 1.11% | 32 |
|
|
2018
Q1 | $37M | Buy |
22,823
+3,516
| +18% | +$5.71M | 1.43% | 27 |
|
|
2017
Q4 | $32.4M | Buy |
19,307
+7,166
| +59% | +$12M | 1.41% | 25 |
|
|
2017
Q3 | $17M | Buy |
12,141
+6,145
| +102% | +$8.6M | 0.84% | 36 |
|
|
2017
Q2 | $6.69M | Buy |
+5,996
| New | +$6.69M | 0.41% | 47 |
|